AI Adoption Surges in Life Sciences Manufacturing as Talent, Risk, and Quality Pressures Intensify
Rockwell Automation (NYSE:ROK) has released its 10th annual "State of Smart Manufacturing Report: Life Sciences Edition," revealing significant trends in AI adoption across life sciences manufacturing. The study, surveying 143 leaders from 15 countries, shows that 95% of manufacturers are either using or evaluating smart technology.
Key findings highlight that companies are primarily using AI for quality improvement (53%), operations streamlining (50%), and cybersecurity enhancement (48%). The report also identifies workforce challenges, with 26% of leaders citing skilled worker recruitment as their biggest growth barrier in 2025. In response, manufacturers are increasingly turning to AI and automation to support their workforce needs.
Rockwell Automation (NYSE:ROK) ha pubblicato il suo 10° rapporto annuale "State of Smart Manufacturing Report: Life Sciences Edition", che evidenzia importanti tendenze nell'adozione dell'intelligenza artificiale nella produzione nel settore delle scienze della vita. Lo studio, che ha coinvolto 143 leader provenienti da 15 paesi, mostra che il 95% dei produttori sta utilizzando o valutando tecnologie intelligenti.
I risultati principali indicano che le aziende impiegano principalmente l'IA per il miglioramento della qualità (53%), la semplificazione delle operazioni (50%) e il rafforzamento della cybersecurity (48%). Il rapporto evidenzia inoltre sfide legate alla forza lavoro, con il 26% dei leader che indica il reclutamento di personale qualificato come il principale ostacolo alla crescita nel 2025. In risposta, i produttori si stanno sempre più orientando verso l'IA e l'automazione per supportare le esigenze del proprio personale.
Rockwell Automation (NYSE:ROK) ha publicado su décimo informe anual "State of Smart Manufacturing Report: Life Sciences Edition", que revela tendencias significativas en la adopción de IA en la fabricación de ciencias de la vida. El estudio, que encuestó a 143 líderes de 15 países, muestra que el 95% de los fabricantes están utilizando o evaluando tecnologías inteligentes.
Los hallazgos clave destacan que las empresas usan principalmente IA para la mejora de la calidad (53%), la optimización de operaciones (50%) y el refuerzo de la ciberseguridad (48%). El informe también identifica desafíos en la fuerza laboral, con un 26% de los líderes que señalan el reclutamiento de trabajadores cualificados como su mayor barrera de crecimiento para 2025. En respuesta, los fabricantes recurren cada vez más a la IA y la automatización para apoyar las necesidades de su personal.
Rockwell Automation (NYSE:ROK)은 10번째 연례 "State of Smart Manufacturing Report: Life Sciences Edition"을 발표하며 생명과학 제조 분야에서 AI 도입의 주요 동향을 공개했습니다. 15개국의 143명 리더를 대상으로 한 조사에서 95%의 제조업체가 스마트 기술을 사용하거나 평가 중임을 보여줍니다.
주요 결과는 기업들이 주로 AI를 품질 향상(53%), 운영 효율화(50%), 사이버 보안 강화(48%)에 활용하고 있음을 강조합니다. 또한 보고서는 인력 문제를 지적하며, 26%의 리더가 2025년 성장의 가장 큰 장애물로 숙련된 인력 채용을 꼽았습니다. 이에 제조업체들은 인력 지원을 위해 AI와 자동화에 점점 더 의존하고 있습니다.
Rockwell Automation (NYSE:ROK) a publié son 10e rapport annuel "State of Smart Manufacturing Report: Life Sciences Edition", révélant des tendances importantes dans l'adoption de l'IA dans la fabrication des sciences de la vie. L'étude, qui a sondé 143 dirigeants de 15 pays, montre que 95 % des fabricants utilisent ou évaluent des technologies intelligentes.
Les principales conclusions soulignent que les entreprises utilisent principalement l'IA pour améliorer la qualité (53 %), rationaliser les opérations (50 %) et renforcer la cybersécurité (48 %). Le rapport identifie également des défis liés à la main-d'œuvre, avec 26 % des dirigeants citant le recrutement de travailleurs qualifiés comme le principal obstacle à la croissance en 2025. En réponse, les fabricants se tournent de plus en plus vers l'IA et l'automatisation pour soutenir leurs besoins en personnel.
Rockwell Automation (NYSE:ROK) hat seinen zehnten jährlichen Bericht "State of Smart Manufacturing Report: Life Sciences Edition" veröffentlicht, der bedeutende Trends bei der Einführung von KI in der Life-Sciences-Produktion aufzeigt. Die Studie, die 143 Führungskräfte aus 15 Ländern befragte, zeigt, dass 95 % der Hersteller intelligente Technologien nutzen oder evaluieren.
Wesentliche Erkenntnisse zeigen, dass Unternehmen KI vor allem für Qualitätsverbesserung (53 %), Optimierung der Abläufe (50 %) und Stärkung der Cybersicherheit (48 %) einsetzen. Der Bericht identifiziert zudem Herausforderungen beim Personal, wobei 26 % der Führungskräfte die Rekrutierung qualifizierter Mitarbeiter als größtes Wachstumshemmnis für 2025 nennen. Als Reaktion darauf setzen Hersteller zunehmend auf KI und Automatisierung, um ihren Personalbedarf zu unterstützen.
- 95% of life sciences manufacturers are adopting or evaluating smart technology, indicating strong market penetration
- Company's expertise and solutions position it well to capitalize on industry digital transformation trends
- Multiple revenue opportunities identified through AI implementation in quality control, operations, and cybersecurity
- Strong focus on long-term value with 66% prioritizing growth and 62% expanding capacity
- Only 46% of manufacturers are effectively using their collected data
- Persistent challenges in skilled worker recruitment could impact growth
- Significant investment required for emerging technologies like generative AI and digital twins
Insights
Rockwell's survey shows near-universal smart manufacturing adoption in life sciences, positioning ROK to capitalize on AI-driven industry transformation.
The latest Rockwell Automation survey reveals a significant market opportunity as 95% of life sciences manufacturers are now using or evaluating smart technology. This represents a crucial inflection point for ROK as the sector's digital transformation accelerates beyond early adoption into mainstream implementation.
The survey identifies clear AI application priorities: quality improvement (53%), operational streamlining (50%), and cybersecurity enhancement (48%). These align perfectly with Rockwell's core competencies in industrial automation solutions. Particularly noteworthy is the 48% of manufacturers turning to AI specifically to address persistent workforce challenges, creating a compelling value proposition for Rockwell's automation platforms.
The data reveals a strategic shift toward long-term digital investment thinking, with manufacturers prioritizing growth (66%) and capacity expansion (62%). This suggests the market is moving beyond experimental pilots toward enterprise-wide digital transformation—expanding Rockwell's potential deal sizes and recurring revenue opportunities.
However, a critical gap remains: despite massive data collection, only 46% of manufacturers effectively utilize this data. This inefficiency represents both a challenge and opportunity for Rockwell to provide more sophisticated data integration and analytics solutions that transform raw operational data into actionable intelligence.
As life sciences manufacturers face increasing regulatory complexity and quality demands, Rockwell's positioning as an end-to-end automation provider with industry-specific expertise creates a competitive advantage in capturing this expanding market.
Global survey reveals how manufacturers are adopting advanced technologies to stay competitive and meet rising patient demands amid economic uncertainty
Life sciences manufacturers are working to keep up with growing demand, rising costs, growing cybersecurity threats, and complex compliance requirements, all while navigating economic uncertainty and ongoing workforce challenges. Many are turning to advanced technologies to help them become more agile and adapt to constant change.
Smart manufacturing is a clear area of focus with
"Life sciences manufacturers are entering a new phase of digital maturity, driven by increasing regulatory complexity and mounting pressure to improve time-to-market without sacrificing quality," said Matt Weaver, Vice President, Global Industry – Life Sciences, Rockwell Automation. "This year's report makes it clear that AI is becoming indispensable to modern life sciences manufacturing—not just to optimize efficiency, but to strengthen product quality, secure critical infrastructure, and upskill the workforce. There's a clear shift toward long-term thinking as leaders double down on digital investments that make operations more connected, adaptive, and resilient."
Key global findings include:
- Smart manufacturing is nearly universal.
95% of life sciences manufacturers are using or evaluating smart technology. - Top use cases for AI are clear. Most companies use AI to improve quality (
53% ), streamline operations (50% ) and strengthen cybersecurity (48% ). - Hiring remains a major challenge.
26% of leaders say finding skilled workers is the biggest barrier to growth in 2025. - Tech is helping fill talent gaps. Nearly half of life sciences manufacturers are turning to AI (
48% ) and automation (46% ) to support their workforce. - Emerging tech is gaining traction.
36% plan to invest in generative or causal AI, and35% are exploring digital twins and simulation tools. - Investments are focused on long-term value. Leaders are prioritizing growth (
66% ), expanding capacity (62% ) and protecting operations (50% ).
Although most manufacturers collect large volumes of data, only
"With our extensive industry expertise and wide-ranging suite of automation and information solutions, Rockwell is uniquely positioned to support life sciences organizations across the globe," said Weaver. "No matter where a company is on their path to digital transformation and smart manufacturing, we can meet them where they are to help them achieve sustainable growth."
The full findings of the report can be found here.
Methodology
The report is based on the responses of 143 managers and executives from Life Science manufacturers, original equipment manufacturers (OEMs), system integrators, and engineering procurement companies (EPCs) in 15 countries. It is part of Rockwell Automation's 10th annual State of Smart Manufacturing report, which surveyed 1,560 decision makers across various industries and was conducted in association with Sapio Research and Rockwell Automation.
About Rockwell Automation
Rockwell Automation, Inc. (NYSE: ROK), is a global leader in industrial automation and digital transformation. We connect the imaginations of people with the potential of technology to expand what is humanly possible, making the world more productive and more sustainable. Headquartered in
View original content to download multimedia:https://www.prnewswire.com/news-releases/ai-adoption-surges-in-life-sciences-manufacturing-as-talent-risk-and-quality-pressures-intensify-302489057.html
SOURCE Rockwell Automation, Inc.
FAQ
What are the main findings of Rockwell Automation's (ROK) 2025 State of Smart Manufacturing Report?
How are life sciences manufacturers addressing workforce challenges in 2025?
What percentage of life sciences manufacturers are effectively using their data according to ROK's report?
What are the main investment priorities for life sciences manufacturers according to Rockwell's study?
What emerging technologies are life sciences manufacturers planning to invest in?
